Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. (DNTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DNTH · as of Jun 8, 2026
Key Statistics
Explore Dianthus Therapeutics, Inc. Data
dnth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The DNTH analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $111.91, representing +38.48% upside from the current price of $80.81.
Competitors & Peers
dnth competitorsDNTH
ANAB
ATAI
BBOT
ELVN
IMTXStock Performance
Full HistoryAbout Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammator…
what is dianthus therapeutics, inc. · dnth stock overview · dianthus therapeutics, inc. company profile · who is dianthus therapeutics, inc. ceo · dnth NASDAQ · dianthus therapeutics, inc. headquarters · dianthus therapeutics, inc. business segments
About Stock Overview & Key Data
Dianthus Therapeutics, Inc. (DNTH) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 21, 2018. As of the latest trading session, DNTH stock price is $80.81, with a market capitalization of $3.4B. The stock has returned +342.61% over the past 12 months and +95.37% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Dianthus Therapeutics, Inc. stock is Buy, with an average 12-month price target of $111.91. In fiscal year 2025, Dianthus Therapeutics, Inc. reported revenue of $2.0M and net income of -$162.3M. For detailed data — including Dianthus Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dianthus Therapeutics, Inc. (DNTH) stock price is $80.81. The stock is traded on NASDAQ under the ticker symbol DNTH. The 52-week range is $16.64 – $96.50.